Testing a new medicine for moderate-to-severe plaque psoriasis
Part of Skin clinical trials.
This study tests an investigational medicine (HS-20118) for people with moderate-to-severe plaque psoriasis. The goal is to see if the drug can safely and effectively reduce psoriasis symptoms and improve quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had plaque psoriasis (the common kind with thick, red, scaly patches) for at least 6 months.
- Your psoriasis covers 10% or more of your body surface area and is moderate to severe (confirmed by your doctor).
- Your doctor agrees that you need a stronger treatment, such as light therapy or oral medication.
- You are not pregnant or breastfeeding, and you and your partner agree to use reliable birth control during the study and for at least 3 months after the last dose.
- You have not had cancer (except for certain early skin cancers or cervical cancer that was fully treated) in the past 5 years.
- You do not have other serious or uncontrolled health problems (like heart, liver, kidney, or mental health conditions) that could interfere with the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine (HS-20137) for moderate-to-severe plaque psoriasis, a condition causing thick, scaly patches on the skin. It aims to see if this medicine can safely reduce the severity of psoriasis and improve quality of life.
This study tests an experimental once-daily tablet for adults with moderate-to-severe plaque psoriasis who haven't had enough relief from standard creams or light therapy. The goal is to see if it can clear skin more effectively than placebo.
This study tests an experimental oral tablet (CMS-D001) to see if it can safely and effectively reduce the severity of moderate to severe plaque psoriasis. It may be an easier treatment option compared to injections or light therapy.
This trial tests a new medication (HS-10374) taken by mouth to see if it is safe and effective for people with moderate to severe plaque psoriasis. It might help reduce the redness, scaling, and thickness of psoriasis plaques.
This trial tests a new study drug called HSK44459 for people with moderate to severe plaque psoriasis. The hope is that the drug can reduce psoriasis symptoms and improve quality of life. Participation involves receiving the study drug and being monitored for safety and effectiveness.
This trial tests an investigational drug, HB0017, in adults with moderate to severe plaque psoriasis. If you have had psoriasis for at least 6 months and have not used certain biologic treatments, you may be able to join.
Hear when a new Moderate to Severe Plaque Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.